THE PROPER STUDY: INTERIM ANALYSIS OF A PAN-EU REAL-WORLD STUDY OF SB5 BIOSIMILAR FOLLOWING TRANSITION FROM REFERENCE ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS, OR PSORIATIC ARTHRITIS - Research portal of Justus Liebig University Giessen:

Meeting Abstract

THE PROPER STUDY: INTERIM ANALYSIS OF A PAN-EU REAL-WORLD STUDY OF SB5 BIOSIMILAR FOLLOWING TRANSITION FROM REFERENCE ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS, OR PSORIATIC ARTHRITIS

Authors list: Mueller-Ladner, U.; Gaffney, K.; Jadon, D.; Freudensprung, U.; Addison, J.

Publication year: 2021

Pages: 1126-1127

Journal: Annals of the Rheumatic Diseases

Volume number: 80

ISSN: 0003-4967

eISSN: 1468-2060

Open access status: Bronze

DOI Link: https://doi.org/10.1136/annrheumdis-2021-eular.844

Conference: Annual European Congress of Rheumatology (EULAR)

Publisher: BMJ Publishing Group

Citation Styles

Harvard Citation style: Mueller-Ladner, U., Gaffney, K., Jadon, D., Freudensprung, U. and Addison, J. (2021) THE PROPER STUDY: INTERIM ANALYSIS OF A PAN-EU REAL-WORLD STUDY OF SB5 BIOSIMILAR FOLLOWING TRANSITION FROM REFERENCE ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS, OR PSORIATIC ARTHRITIS, Annals of the Rheumatic Diseases, 80, pp. 1126-1127. https://doi.org/10.1136/annrheumdis-2021-eular.844

APA Citation style: Mueller-Ladner, U., Gaffney, K., Jadon, D., Freudensprung, U., & Addison, J. (2021). THE PROPER STUDY: INTERIM ANALYSIS OF A PAN-EU REAL-WORLD STUDY OF SB5 BIOSIMILAR FOLLOWING TRANSITION FROM REFERENCE ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS, OR PSORIATIC ARTHRITIS. Annals of the Rheumatic Diseases. 80, 1126-1127. https://doi.org/10.1136/annrheumdis-2021-eular.844

SDG Areas